Taisho Pharmaceutical Holdings Co (TSE:4581) Buildings And Improvements : 円80,031 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Buildings And Improvements?

Taisho Pharmaceutical Holdings Co's quarterly buildings and improvements increased from Jun. 2023 (円55,144 Mil) to Sep. 2023 (円79,932 Mil) and increased from Sep. 2023 (円79,932 Mil) to Dec. 2023 (円80,031 Mil).

Taisho Pharmaceutical Holdings Co's annual buildings and improvements increased from Mar. 2021 (円172,499 Mil) to Mar. 2022 (円174,360 Mil) but then declined from Mar. 2022 (円174,360 Mil) to Mar. 2023 (円55,545 Mil).

Taisho Pharmaceutical Holdings Co Buildings And Improvements Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Buildings And Improvements Chart

Taisho Pharmaceutical Holdings Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Buildings And Improvements

Get a 7-Day Free Trial

152,695.00

174,309.00

172,499.00

174,360.00

55,545.00

Taisho Pharmaceutical Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Buildings And Improvements	Get a 7-Day Free Trial															55,684.00	55,545.00	55,144.00	79,932.00	80,031.00

Taisho Pharmaceutical Holdings Co Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

TAIPY:USA TAISF:USA

Address

3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655

Website

http://www.taisho-holdings.co.jp

Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines